Hirtle Callaghan & Co’s Oracle ORCL Stock Holding History

Hirtle Callaghan & Co’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,099	Closed	-$516K	–	119
2024 Q4	$516K	Buy	3,099 +199	+7%	+$35.4K	0.02%	82
2024 Q3	$494K	Buy	+2,900	New	+$420K	0.02%	77
2019 Q1	–	Sell	-16,900	Closed	-$763K	–	115
2018 Q4	$763K	Hold	16,900	–	–	0.07%	43
2018 Q3	$871K	Hold	16,900	–	–	0.08%	41
2018 Q2	$745K	Sell	16,900 -3,300	-16%	-$152K	0.07%	44
2018 Q1	$924K	Hold	20,200	–	–	0.09%	36
2017 Q4	$955K	Hold	20,200	–	–	0.09%	36
2017 Q3	$977K	Buy	+20,200	New	+$1.01M	0.1%	34
2016 Q4	–	Sell	-20,200	Closed	-$793K	–	188
2016 Q3	$793K	Hold	20,200	–	–	0.16%	35
2016 Q2	$827K	Hold	20,200	–	–	0.15%	36
2016 Q1	$826K	Buy	+20,200	New	+$748K	0.15%	36
2015 Q4	–	Sell	-775	Closed	-$28K	–	171
2015 Q3	$28K	Hold	775	–	–	﹤0.01%	163
2015 Q2	$31K	Buy	+775	New	+$33.6K	0.01%	163
2015 Q1	–	Sell	-35,021	Closed	-$1.57M	–	266
2014 Q4	$1.57M	Buy	+35,021	New	+$1.43M	0.37%	45
2014 Q3	–	Sell	-43,041	Closed	-$1.74M	–	609
2014 Q2	$1.74M	Buy	43,041 +7,800	+22%	+$321K	0.24%	62
2014 Q1	$1.44M	Sell	35,241 -1,000	-3%	-$38.1K	0.24%	54
2013 Q4	$1.39M	Buy	36,241 +1,387	+4%	+$47.7K	0.19%	62
2013 Q3	$1.16M	Buy	+34,854	New	+$1.13M	0.19%	69

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Hirtle Callaghan & Co's ORCL Position: Q1 2025 in Review

Hirtle Callaghan & Co sold out of Oracle (ORCL) in Q1 2025, closing a stake of 3,099 shares — an estimated $516K sold.

Hirtle Callaghan & Co first reported a position in ORCL in Q3 2013 and held it in 18 quarters. The position peaked at $1.74M in Q2 2014. 3,245 funds tracked by Wall St. Rank hold ORCL as of Q1 2025.

Hirtle Callaghan & Co reported no remaining Oracle position as of Q1 2025 after selling out during the quarter.
Hirtle Callaghan & Co sold 3,099 Oracle shares in Q1 2025, an estimated $516K.
Hirtle Callaghan & Co first reported a position in Oracle in Q3 2013 and held it in 18 quarters.
Hirtle Callaghan & Co's Oracle position peaked at $1.74M in Q2 2014.
3,245 funds tracked by Wall St. Rank held Oracle as of Q1 2025.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2025, filed 12 May 2025.